Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

Frontiers in Oncology

Volumn 4, Issue NOV, 2014, Pages

  Kahn, Jenna ^a,b   Gillespie, Andy ^a   Tsokos, Maria ^c   Ondos, John ^a   Dombi, Eva ^a   Camphausen, Kevin ^a   Widemann, Brigitte C ^a   Kaushal, Aradhana ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Malignant peripheral nerve sheath tumor; Malignant schwannoma; Neurofibrosarcoma; Neurogenic sarcoma; Radiation therapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; DESQUAMATION; DYSPHAGIA; ERYTHEMA; FATIGUE; FEMALE; HISTOLOGY; HUMAN; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NAUSEA; NEUROFIBROMATOSIS; ODYNOPHAGIA; OVERALL SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 84925014236     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00324     Document Type: Article

References (35)

1. Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol (2005) 23:8422-30. doi:10.1200/JCO.2005.01.4886
2. Doorn PF, Molenaar WM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 21:78-82. doi:10.1016/S0748-7983(05)80073-3
3. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer (1986) 57:2006-21. doi:10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6
4. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 71:1247-53. doi:10.1002/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S
5. Kar M, Deo SV, Shukla NK, Malik A, DattaGupta S, Mohanti BK, et al. Malignant peripheral nerve sheath tumors (MPNST) - clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol (2006) 4:55. doi:10.1186/1477-7819-4-55
6. Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg (2009) 249:1014-22. doi:10.1097/SLA.0b013e3181a77e9a
7. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer (2006) 107:1065-74. doi:10.1002/cncr.22098
8. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet (2002) 39:311-4. doi:10.1136/jmg.39.5.311
9. Ghosh BC, Ghosh L, Huvos AG, Fortner JG. Malignant schwannoma. A clinicopathologic study. Cancer (1973) 31:184-90. doi:10.1002/1097-0142(197301)31:1<184::AID-CNCR2820310126>3.0.CO;2-8
10. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys (1998) 42:351-60. doi:10.1016/S0360-3016(98)00223-5
11. Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, et al. Malignant peripheral nerve sheath tumors (MPNST): the mayo clinic experience. Ann Surg Oncol (2012) 19(3):878-85. doi:10.1245/s10434-011-1978-7
12. Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol (2011) 34:417-21. doi:10.1097/COC.0b013e3181e9c08a
13. Ferrari A, Miceli R, Rey A, Oberlin O, Orbach D, Brennan B, et al. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from united states and European groups. Eur J Cancer (2011) 47:724-31. doi:10.1016/j.ejca.2010.11.013
14. Storm FK, Eilber FR, Mirra J, Morton DL. Neurofibrosarcoma. Cancer (1980) 45:126-9. doi:10.1002/1097-0142(19800101)45:1<126::AID-CNCR2820450122>3.0.CO;2-U
15. Hruban RH, Shiu MH, Senie RT, WoodruffJM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer (1990) 66:1253-65. doi:10.1002/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R
16. Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology (2003) 61:696-8. doi:10.1212/01.WNL.0000078813.05925.2C
17. Casanova M, Ferrari A, Spreafico F, Luksch R, Terenziani M, Cefalo G, et al. Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol (1999) 21:509-13. doi:10.1097/00043426-199911000-00011
18. Kourea HP, Bilsky MH, Leung DH, Lewis JJ, WoodruffJM. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer (1998) 82:2191-203. doi:10.1002/(SICI)1097-0142(19980601)82:11<2191::AID-CNCR14>3.0.CO;2-P
19. Smith KB, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Kirwan JM, et al. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (2011) 81:150-7. doi:10.1016/j.ijrobp.2010.05.005
20. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res (2002) 62:1573-7.
21. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol (2012) 123:295-319. doi:10.1007/s00401-012-0954-z
22. Sordillo PP, Helson L, Hajdu SI, Magill GB, KosloffC, Golbey RB, et al. Malignant schwannoma - clinical characteristics, survival, and response to therapy. Cancer (1981) 47:2503-9. doi:10.1002/1097-0142(19810515)47:10<2503::AID-CNCR2820471033>3.0.CO;2-3
23. de Cou JM, Rao BN, Parham DM, Lobe TE, Bowman L, Pappo AS, et al. Malignant peripheral nerve sheath tumors: the St. Jude children's research hospital experience. Ann Surg Oncol (1995) 2:524-9. doi:10.1007/BF02307086
24. Ramanathan RC, Thomas JM. Malignant peripheral nerve sheath tumours associated with von Recklinghausen's neurofibromatosis. Eur J Surg Oncol (1999) 25:190-3. doi:10.1053/ejso.1998.0625
25. Hagel C, Zils U, Peiper M, Kluwe L, Gotthard S, Friedrich RE, et al. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neurooncol (2007) 82:187-92. doi:10.1007/s11060-006-9266-2
26. LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, et al. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol (2012) 20(1):66-72. doi:10.1245/s10434-012-2573-2
27. Zöller ME, Rembeck B, Odén A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer (1997) 79:2125-31. doi:10.1002/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.3.CO;2-B
28. Koshy S. Soft-tissue considerations in mandibular setback. Am J Orthod Dentofacial Orthop (2010) 137:447-8. doi:10.1016/j.ajodo.2010.02.011
29. Widemann BC. Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Curr Oncol Rep (2009) 11:322-8. doi:10.1007/s11912-009-0045-z
30. Basso-Ricci S. Therapy of malignant schwannomas: usefulness of an integrated radiologic. Surgical therapy. J Neurosurg Sci (1989) 33:253-7.
31. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 16:197-203.
32. Mundt AJ, Awan A, Sibley GS, Simon M, Rubin SJ, Samuels B, et al. Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys (1995) 32:977-85. doi:10.1016/0360-3016(95)00111-B
33. Koshy M, Rich SE, Mohiuddin MM. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: a seer analysis. Int J Radiat Oncol Biol Phys (2010) 77:203-9. doi:10.1016/j.ijrobp.2009.04.051
34. Pisters PW, Harrison LB, Leung DH, WoodruffJM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 14:859-68.
35. Alektiar KM, Brennan MF, Singer S. Local control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity. Cancer (2011) 117:3229-34. doi:10.1002/cncr.25882